This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Matsuno, H. Articles by Uematsu, T. Search for Related Content PubMed PubMed Citation Articles by Matsuno, H. Articles by Uematsu, T.

(Circulation. 1997;96:1299-1304.)
© 1997 American Heart Association, Inc.

Articles

Inhibition of von Willebrand Factor Binding to Platelet GP Ib by a Fractionated Aurintricarboxylic Acid Prevents Restenosis After Vascular Injury in Hamster Carotid Artery

Hiroyuki Matsuno, PhD; Osamu Kozawa, MD, PhD; Masayuki Niwa, PhD; ; Toshihiko Uematsu, MD, PhD

From the Department of Pharmacology, Gifu University School of Medicine, Japan.

Correspondence to Hiroyuki Matsuno, PhD, Department of Pharmacology, Gifu University, Tsukasa-machi 40, Gifu 500, Japan. E-mail leuven{at}cc.gifu-u.ac.jp

Background Aurintricarboxylic acid (ATA) prevents von Willebrand factor binding to platelet glycoprotein (GP) Ib, with higher-molecular-weight ATA more effective than the lower-molecular-weight compound. We investigated the effects of high-molecular-weight ATA (M_r=7500), obtained by fractionating commercial ATA, in the injured hamster carotid artery.

Methods and Results Platelet aggregation was induced in vitro with ADP (2.5 µmol/L) or botrocetin (5 µg/mL) in hamster platelet-rich plasma. IC₅₀ values were 348.6±22.4 and 8.2±3.2 µg/mL, respectively. The endothelium of hamster carotid artery was denuded with a modified catheter. Continuous administration of high-molecular-weight ATA (10, 30, and 100 µg·kg^-1·h^-1) with an infusion pump produced antithrombotic effects in a dose-dependent manner, as evaluated by prolongation of time to occlusion. Neointima formation was observed 2 weeks after catheterization, and proliferating smooth muscle cells (SMCs) were identified by the thymidine analogue 5-bromo-2-deoxy-uridine (BrdU). Continuous treatment with the compound (100 µg·kg^-1·h^-1) with a 2ML1 Alzet infusion pump resulted in a reduction of neointimal area by 38.0±8.8% and decreased the BrdU index on days 1 and 7 significantly. DNA synthesis in DDT1MF2 hamster SMCs was also decreased by the compound in a dose-dependent manner. In histological observation, the process of endothelial healing was improved by this treatment with the compound.

Conclusions Inhibition of platelet adhesion by von Willebrand factor binding to platelet GP Ib by high-molecular-weight ATA results in the prevention of thrombus formation and the suppression of neointima lesion. In addition, high-molecular-weight ATA has an inhibitory effect on SMC proliferation. This inhibition of both platelet adhesion and SMC proliferation markedly reduced vascular stenosis.

Key Words: platelets • stenosis • arteries • von Willebrand factor • glycoproteins

This article has been cited by other articles:

				H. Matsuno, H. Tokuda, A. Ishisaki, Y. Zhou, Y. Kitajima, and O. Kozawa P2Y12 Receptors Play a Significant Role in the Development of Platelet Microaggregation in Patients with Diabetes J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 920 - 927. [Abstract] [Full Text] [PDF]

				H. Matsuno, A. Ishisaki, K. Nakajima, K. Okada, S. Ueshima, O. Matsuo, and O. Kozawa Lack of {alpha}2-antiplasmin promotes re-endothelialization via over-release of VEGF after vascular injury in mice Blood, November 15, 2003; 102(10): 3621 - 3628. [Abstract] [Full Text] [PDF]

				H. V. Anderson, J. McNatt, F. J. Clubb, M. Herman, J.-P. Maffrand, F. DeClerck, C. Ahn, L. M. Buja, and J. T. Willerson Platelet Inhibition Reduces Cyclic Flow Variations and Neointimal Proliferation in Normal and Hypercholesterolemic-Atherosclerotic Canine Coronary Arteries Circulation, November 6, 2001; 104(19): 2331 - 2337. [Abstract] [Full Text] [PDF]

				S. Kageyama, H. Yamamoto, and R. Yoshimoto Anti-Human von Willebrand Factor Monoclonal Antibody AJvW-2 Prevents Thrombus Deposition and Neointima Formation After Balloon Injury in Guinea Pigs Arterioscler. Thromb. Vasc. Biol., October 1, 2000; 20(10): 2303 - 2308. [Abstract] [Full Text] [PDF]

				M. Harada, Y. Toki, Y. Numaguchi, H. Osanai, T. Ito, K. Okumura, and T. Hayakawa Prostacyclin synthase gene transfer inhibits neointimal formation in rat balloon-injured arteries without bleeding complications Cardiovasc Res, August 1, 1999; 43(2): 481 - 491. [Abstract] [Full Text] [PDF]

				K. Eto, T. Isshiki, H. Yamamoto, S. Takeshita, M. Ochiai, N. Yokoyama, R. Yoshimoto, Y. Ikeda, and T. Sato AJvW-2, an Anti-vWF Monoclonal Antibody, Inhibits Enhanced Platelet Aggregation Induced by High Shear Stress in Platelet-Rich Plasma From Patients With Acute Coronary Syndromes Arterioscler. Thromb. Vasc. Biol., April 1, 1999; 19(4): 877 - 882. [Abstract] [Full Text] [PDF]

				Y. Numaguchi, K. Naruse, M. Harada, H. Osanai, S. Mokuno, K. Murase, H. Matsui, Y. Toki, T. Ito, K. Okumura, et al. Prostacyclin Synthase Gene Transfer Accelerates Reendothelialization and Inhibits Neointimal Formation in Rat Carotid Arteries After Balloon Injury Arterioscler. Thromb. Vasc. Biol., March 1, 1999; 19(3): 727 - 733. [Abstract] [Full Text] [PDF]

				B. J. Fredrickson, J.-F. Dong, L. V. McIntire, and J. A. Lopez Shear-Dependent Rolling on von Willebrand Factor of Mammalian Cells Expressing the Platelet Glycoprotein Ib-IX-V Complex Blood, November 15, 1998; 92(10): 3684 - 3693. [Abstract] [Full Text] [PDF]

				R. Altman Controversies in Antithrombotic Therapy in Cardiovascular Diseases Clinical and Applied Thrombosis/Hemostasis, January 1, 1998; 4(1): 11 - 24. [Abstract] [PDF]